A Service Evaluation of the Clinical Use of Parkinson’s KinetiGraph (PKG) Movement Recording System in the Assessment of Parkinson’s Disease Patients with Tremor
Objective: To evaluate the clinical usefulness of PKG Movement Recording System in the assessment process to aid recognition and understanding of tremor in patients with Parkinson’s disease…Acquisition, Validation and Preprocessing of Wrist-Worn Sensor Data in Patients with Parkinson’s Disease and Healthy Controls
Objective: We describe relevant aspects and data processing steps for accelerometry and gyroscopy recordings made with a wrist-worn low-cost sensor device. In order to generalize…Variability of spiral tremor during daily life of subjects with Essential Tremor
Objective: To explore the long-term variability and reliability of tremor severity in Archimedes spirals in patients with Essential Tremor (ET). Background: ET affects activities of…Efficacy of rotigotine as measured by individual Unified Parkinson’s Disease Rating Scale II and III items: a post-hoc analysis
Objective: The key aim was to assess the efficacy of rotigotine (RTG) transdermal patch on individual items of Unified Parkinson’s Disease Rating Scale (UPDRS) II…Validation of a performance-based assessment of functional ability related to cognition in Parkinson’s disease
Objective: Validate the University of California San Diego Performance-Based Skills Assessment (UPSA) in Parkinson's disease (PD) Background: Diagnostic criteria for PD dementia (PDD) require significant…Sample size estimation for clinical trials in de novo Parkinson’s disease (PD): Results from the Parkinson’s Progression Markers Initiative (PPMI) Study
Objective: To use clinical and biological data from PPMI to estimate sample size for disease modification studies in de novo PD Background: One barrier to…Classification of neurocognitive impairment in Spanish speaking Parkinson’s disease patients
Objective: To examine differences between United States (US) and Latin American (LA) norms classifying cognitive impairment using standardized neuropsychological measures to assess cognition in Parkinson’s…Five year longitudinal change in the MDS-UPDRS scores in early Parkinson’s disease participants: Results from the PPMI Study
Objective: To determine the longitudinal change in the Movement Disorder Society –Unified Parkinson’s Disease Rating Scale (MDS-UPDRS) in Parkinson’s disease (PD) participants who were untreated…Which self-report motor experiences of daily living best predict objective motor function in patients with Parkinson’s disease?
Objective: To identify the most important self-reported motor experience predictors of objective measures of motor impairment in patients with Parkinson's disease (PD). Background: The MDS-UPDRS has…Improving Clinical Trials Through Patient Input: Outcomes of a Partnership Between Pfizer and the Parkinson’s Disease Foundation
Objective: To identify the outcomes of the partnership between Pfizer and the Parkinson’s Disease Foundation (PDF), which was designed to 1. increase understanding of the…
- « Previous Page
- 1
- …
- 24
- 25
- 26
- 27
- 28
- …
- 32
- Next Page »